Exelixis (EXEL) Divestments (2010 - 2015)
Exelixis (EXEL) posted quarterly Divestments of $95000.0 for Q1 2015, down 88.12% quarter-over-quarter from $800000.0 in Q3 2014.
Powered by 
Analysis
Exelixis (EXEL) Divestments (2010 - 2015) Analysis & Trends
Exelixis' Divestments history runs 3 years deep, the most recent figure standing at $95000.0 for Q1 2015.
- In Q1 2015, Divestments changed N/A year-over-year to $95000.0; the TTM figure through Jun 2015 stood at $895000.0 (changed N/A YoY), while the FY2014 annual figure was $838000.0, changed N/A from the prior year.
- Divestments for Q1 2015 stood at $95000.0, down from $800000.0 in the prior quarter.
- The five-year high for Divestments was $800000.0 in Q3 2014, with the low at $95000.0 in Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -13.21 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Exelixis | 14.81 Bn | 13.97 Bn | 608.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2015 | 95,000.00 |
| Sep 30, 2014 | 800,000.00 |
| Dec 31, 2010 | 400,000.00 |